A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma	Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 1	2026-09-25		NCT06604715

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	338
China Medical University Hospital	Taichung	Taiwan	36
Clinica Univ. de Navarra	Pamplona	Spain	42
Hosp Clinic de Barcelona	Barcelona	Spain	37
Hosp Clinico Univ de Salamanca	Salamanca	Spain	34
Hosp Univ Fund Jimenez Diaz	Madrid	Spain	33
Hosp. Univ. Germans Trias I Pujol	Badalona	Spain	28
Jewish General Hospital	Montreal	Canada	130
Kaohsiung Chang Gung Memorial Hospital	Kaohsiung City	Taiwan	19
National Cheng Kung University Hospital	Tainan	Taiwan	52
National Taiwan University Hospital	Taipei	Taiwan	52
Princess Margaret Hospital	Toronto	Canada	21
Samsung Medical Center	Seoul	South Korea	375
Seoul National University Hospital	Seoul	South Korea	393
The Catholic University of Korea Seoul St Marys Hospital	Seoul	South Korea	2